LE 135 structure
|
Common Name | LE 135 | ||
---|---|---|---|---|
CAS Number | 155877-83-1 | Molecular Weight | 438.561 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 601.3±55.0 °C at 760 mmHg | |
Molecular Formula | C29H30N2O2 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 317.5±31.5 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of LE 135LE135 is a potent RAR antagonist that binds selectively to RARα (Ki of 1.4 μM) and RARβ (Ki of 220 nM), and has a higher affinity to RARβ. LE135 is highly selective over RARγ, RXRα, RXRβ and RXRγ. LE135 is also a potent TRPV1 and TRPA1 receptors activator with EC50s of 2.5 μM and 20 μM, respectively[1][2]. |
Name | 4-(5,7,7,10,10-pentamethyl-8,9-dihydronaphtho[2,3-b][1,4]benzodiazepin-13-yl)benzoic acid |
---|---|
Synonym | More Synonyms |
Description | LE135 is a potent RAR antagonist that binds selectively to RARα (Ki of 1.4 μM) and RARβ (Ki of 220 nM), and has a higher affinity to RARβ. LE135 is highly selective over RARγ, RXRα, RXRβ and RXRγ. LE135 is also a potent TRPV1 and TRPA1 receptors activator with EC50s of 2.5 μM and 20 μM, respectively[1][2]. |
---|---|
Related Catalog | |
Target |
RARβ:220 nM (Ki) RARα:1400 nM (Ki) TRPV1:2.5 μM (EC50) TRPA1:20 μM (EC50) |
In Vitro | LE135 inhibits Am80-induced differentiation of human promyelocytic leukemia cells HL-60 with an IC50 of 150 nM[1]. LE135 inhibits retinoic acid (RA)-induced transcriptional activation of RARβ, but not RARα, RARγ or retinoid X receptor α (RXRα), on a variety of RA response elements. LE135 strongly represses 12-O-tetradecanoylphorbol-13-acetate-induced AP-1 activity in the presence of RARβ and RXRα[3]. |
In Vivo | LE135 provokes nociceptive responses and elicited thermal hyperalgesia mainly through TRPV1 channels, but required both TRPA1 and TRPV1 channels for producing mechanical allodynia. Intraplantar injection of LE135 (30 nmol/10 μL) induces mechanical hypersensitivity in wild-type and Trpa1−/− mice[2]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 601.3±55.0 °C at 760 mmHg |
Molecular Formula | C29H30N2O2 |
Molecular Weight | 438.561 |
Flash Point | 317.5±31.5 °C |
Exact Mass | 438.230713 |
PSA | 52.90000 |
LogP | 7.36 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.628 |
Storage condition | 2-8°C |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319 |
Precautionary Statements | P305 + P351 + P338 |
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |
4-(5,7,7,10,10-Pentamethyl-7,8,9,10-tetrahydro-5H-benzo[e]naphtho[2,3-b][1,4]diazepin-13-yl)benzoic acid |
hms3268h07 |
Benzoic acid, 4-(7,8,9,10-tetrahydro-5,7,7,10,10-pentamethyl-5H-benzo[e]naphtho[2,3-b][1,4]diazepin-13-yl)- |
le 135 |